We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Compounder Nets Warning Letter for Insanitary, cGMP Issues
Compounder Nets Warning Letter for Insanitary, cGMP Issues
The FDA served Auro Pharmacies — a California-based compounder — with a warning letter after the agency determined the firm produced products under insanitary conditions.